Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.

Arora, Shitij; Hemmige, Vagish S; Mandke, Charuta; Chansoria, Mayank; Rawat, Sumit Kumar; Dravid, Ameet; Sethi, Yatin; Medikeri, Gaurav; Jariwala, Sunit P; Puius, Yoram A

Arora, Shitij; Hemmige, Vagish S; Mandke, Charuta; Chansoria, Mayank; Rawat, Sumit Kumar; Dravid, Ameet; Sethi, Yatin; Medikeri, Gaurav; Jariwala, Sunit P; Puius, Yoram A.

Emerg Infect Dis ; 27(11): 2963-2965, 2021.

Article in English | MEDLINE | ID: covidwho-1444022

ABSTRACT

ABSTRACT

We established an online registry of coronavirus disease-associated mucormycosis cases in India. We analyzed data from 65 cases diagnosed during April-June 2021, when the Delta variant predominated, and found that patients frequently received antibacterial drugs and zinc supplementation. Online registries rapidly provide relevant data for emerging infections.

Subject(s)

COVID-19; Mucormycosis; Humans; India/epidemiology; Mucormycosis/diagnosis; Mucormycosis/drug therapy; Mucormycosis/epidemiology; Registries; SARS-CoV-2

Keywords

2019 novel coronavirus disease; COVID-19; India; SARS-CoV-2; coronavirus disease; coronaviruses; corticosteroids; fungal infections; fungi; fungus; mucormycosis; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mucormycosis Type of study: Diagnostic study / Observational study Topics: Variants Limits: Humans Country/Region as subject: Asia Language: English Journal: Emerg Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google